Staphylococcus aureus meningitis in adults: A comparative cohort study of infections caused by meticillin-resistant and meticillin-susceptible strains.


Journal

The Journal of hospital infection
ISSN: 1532-2939
Titre abrégé: J Hosp Infect
Pays: England
ID NLM: 8007166

Informations de publication

Date de publication:
May 2019
Historique:
received: 12 09 2018
accepted: 11 11 2018
pubmed: 19 11 2018
medline: 14 6 2019
entrez: 19 11 2018
Statut: ppublish

Résumé

Staphylococcus aureus meningitis is an uncommon nosocomial infection usually associated with neurosurgical procedures, but spontaneous infections may occasionally appear. To compare the features of meningitis caused by meticillin-resistant (MRSA) and meticillin-susceptible (MSSA) S. aureus and examine the prognostic factors for mortality, including MRSA infection and combined antimicrobial therapy. Retrospective cohort study of 350 adults with S. aureus meningitis admitted to 11 hospitals in Spain (1981-2015). Logistic regression and propensity score matching were used to analyse prognostic factors. There were 118 patients (34%) with MRSA and 232 (66%) with MSSA. Postoperative infection (91% vs 73%) and nosocomial acquisition (93% vs 74%) were significantly more frequent in MRSA than in MSSA meningitis (P < 0.001). Combined therapy was given to 118 (34%) patients. Overall 30-day mortality rate was 23%. On multivariate analysis, mortality was associated with severe sepsis or shock (odds ratio (OR) 9.9, 95% confidence interval (CI) 4.5-22.0, P < 0.001), spontaneous meningitis (OR 4.2, 95% CI 1.9-9.1, P < 0.001), McCabe-Jackson score rapidly or ultimately fatal (OR 2.8, 95% CI 1.4-5.4, P = 0.002), MRSA infection (OR 2.6, 95% CI 1.3-5.3, P = 0.006), and coma (OR 2.6, 95% CI 1.1-6.1, P < 0.029). In postoperative cases, mortality was related to retention of cerebrospinal devices (OR 7.9, 95% CI 3.1-20.3, P < 0.001). Clinical and epidemiological differences between MRSA and MSSA meningitis may be explained by the different pathogenesis of postoperative and spontaneous infection. In addition to the severity of meningitis and underlying diseases, MRSA infection was associated with increased mortality. Combined antimicrobial therapy was not associated with increased survival.

Sections du résumé

BACKGROUND BACKGROUND
Staphylococcus aureus meningitis is an uncommon nosocomial infection usually associated with neurosurgical procedures, but spontaneous infections may occasionally appear.
AIMS OBJECTIVE
To compare the features of meningitis caused by meticillin-resistant (MRSA) and meticillin-susceptible (MSSA) S. aureus and examine the prognostic factors for mortality, including MRSA infection and combined antimicrobial therapy.
METHODS METHODS
Retrospective cohort study of 350 adults with S. aureus meningitis admitted to 11 hospitals in Spain (1981-2015). Logistic regression and propensity score matching were used to analyse prognostic factors.
RESULTS RESULTS
There were 118 patients (34%) with MRSA and 232 (66%) with MSSA. Postoperative infection (91% vs 73%) and nosocomial acquisition (93% vs 74%) were significantly more frequent in MRSA than in MSSA meningitis (P < 0.001). Combined therapy was given to 118 (34%) patients. Overall 30-day mortality rate was 23%. On multivariate analysis, mortality was associated with severe sepsis or shock (odds ratio (OR) 9.9, 95% confidence interval (CI) 4.5-22.0, P < 0.001), spontaneous meningitis (OR 4.2, 95% CI 1.9-9.1, P < 0.001), McCabe-Jackson score rapidly or ultimately fatal (OR 2.8, 95% CI 1.4-5.4, P = 0.002), MRSA infection (OR 2.6, 95% CI 1.3-5.3, P = 0.006), and coma (OR 2.6, 95% CI 1.1-6.1, P < 0.029). In postoperative cases, mortality was related to retention of cerebrospinal devices (OR 7.9, 95% CI 3.1-20.3, P < 0.001).
CONCLUSIONS CONCLUSIONS
Clinical and epidemiological differences between MRSA and MSSA meningitis may be explained by the different pathogenesis of postoperative and spontaneous infection. In addition to the severity of meningitis and underlying diseases, MRSA infection was associated with increased mortality. Combined antimicrobial therapy was not associated with increased survival.

Identifiants

pubmed: 30448277
pii: S0195-6701(18)30595-4
doi: 10.1016/j.jhin.2018.11.008
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

108-115

Informations de copyright

Copyright © 2018 The Healthcare Infection Society. Published by Elsevier Ltd. All rights reserved.

Auteurs

V Pintado (V)

Infectious Diseases Service, Hospital Ramón y Cajal, IRYCIS, Madrid, Spain. Electronic address: vpintado.hrc@salud.madrid.org.

R Pazos (R)

Infectious Diseases Service, Hospital Ramón y Cajal, IRYCIS, Madrid, Spain; Department of Biomedical Sciences and Medicine, Universidade do Algarve, Faro, Portugal.

M E Jiménez-Mejías (ME)

Clinical Unit of Infectious Diseases, Microbiology and Preventive Medicine, Infectious Diseases Research Group, Institute of Biomedicine of Seville (IBIS), University of Seville/CSIC/University Hospital Virgen del Rocío, Seville, Spain.

A Rodríguez-Guardado (A)

Infectious Diseases Unit, Hospital Central de Asturias, Oviedo, Spain.

B Díaz-Pollán (B)

Infectious Diseases Unit/Department of Internal Medicine, Hospital La Paz, Madrid, Spain.

C Cabellos (C)

Infectious Diseases Service, Hospital Bellvitge, L'Hospitalet, Barcelona, Spain.

J M García-Lechuz (JM)

Clinical Microbiology Service, Hospital Universitario Miguel Servet, Zaragoza, Spain; Department of Clinical Microbiology, Hospital Gregorio Marañon, Madrid, Spain.

J Lora-Tamayo (J)

Internal Medicine Department, Hospital 12 de Octubre, Madrid, Spain.

P Domingo (P)

Infectious Diseases Unit, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.

E Muñez (E)

Infectious Diseases Unit, Hospital Puerta de Hierro-Majadahonda, Madrid, Spain.

D Domingo (D)

Microbiology Service, Hospital de La Princesa, Madrid, Spain.

F González-Romo (F)

Clinical Microbiology Service, Hospital Clínico San Carlos, Madrid, Spain.

J A Lepe-Jiménez (JA)

Clinical Unit of Infectious Diseases, Microbiology and Preventive Medicine, Infectious Diseases Research Group, Institute of Biomedicine of Seville (IBIS), University of Seville/CSIC/University Hospital Virgen del Rocío, Seville, Spain.

C Rodríguez-Lucas (C)

Infectious Diseases Unit, Hospital Central de Asturias, Oviedo, Spain.

A Gil (A)

Infectious Diseases Unit/Department of Internal Medicine, Hospital La Paz, Madrid, Spain.

I Pelegrín (I)

Infectious Diseases Service, Hospital Bellvitge, L'Hospitalet, Barcelona, Spain.

F Chaves (F)

Clinical Microbiology Department, Hospital 12 de Octubre, Madrid, Spain.

V Pomar (V)

Infectious Diseases Unit, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.

A Ramos (A)

Infectious Diseases Unit, Hospital Puerta de Hierro-Majadahonda, Madrid, Spain.

T Alarcón (T)

Microbiology Service, Hospital de La Princesa, Madrid, Spain.

E Pérez-Cecilia (E)

Clinical Microbiology Service, Hospital Clínico San Carlos, Madrid, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH